Evidence map›Paper›PMID 40442443›Full record

ArticleDiscover oncology2025

HOTAIR, a ferroptosis-related gene, promotes malignant behavior of breast cancer via sponging miR-206.

Wei Wu, Zhihan Yao, Yongxing Chen, Rongxuan Xu, Chenxin Jin, Xiaofeng Li

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei WuDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.
Zhihan YaoDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.
Yongxing ChenDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.
Rongxuan XuDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.
Chenxin JinDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.
Xiaofeng LiDepartment of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China. lxf_chen@dmu.edu.cn.

Funding

the Foundation of Liaoning Province Education Administration No. LJKZ0849
6 · The paper itself

Abstract

Ferroptosis, an iron-dependent regulated cell death modality driven by lipid peroxidation cascades, has emerged as a critical pathogenic mechanism in tumorigenesis and therapeutic resistance. The long non-coding RNA HOTAIR (HOX transcript antisense RNA), previously recognized as a key epigenetic modulator in tumor biology, orchestrates malignant phenotypes through regulation of cell cycle dynamics, proliferative signaling, and metastatic potential. Despite these advances, the mechanistic interface between HOTAIR-mediated ceRNA networks and ferroptosis regulation in breast carcinogenesis remains undefined. Bioinformatic analysis and RT-qPCR validation precisely mapped the subcellular localization and interaction networks of this regulatory axis. Key findings revealed that HOTAIR silencing functionally promotes malignant phenotypes (proliferation, migration and invasion), and mechanistically serves as a molecular sponge for miR-206, thereby de-repressing CERS2 expression to modulate ferroptosis susceptibility. Given the established correlation between HOTAIR silencing and ferroptosis in BRCA, our data suggest that pharmacological induction of ferroptosis represents a promising therapeutic paradigm for this molecular subset. This work not only deciphers a novel HOTAIR/miR-206/CERS2 axis in ferroptosis regulation but also provides translational insights for developing biomarker-driven treatment strategies in refractory breast malignancies.

Indexed as

Breast cancerCeRNAFerroptosisHOTAIRRegulation

Identifiers

PMID40442443
PMCPMC12122935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.